NCT00555750View on ClinicalTrials.gov

Sleep Loss and Mechanisms of Impaired Glucose Metabolism

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

July 31, 2008

Study Completion Date

August 31, 2008

Conditions
Primary Insomnia
Interventions
DRUG

eszopiclone

3mg tablet, by mouth nightly 30 min before bed, for two months

DRUG

placebo

inactive placebo tablet, by mouth nightly 30 minutes before bed, for two months

Trial Locations (1)

02115

Brigham and Women's Hospital, Division of Sleep Medicine, Boston

All Listed Sponsors
collaborator

Sumitomo Pharma America, Inc.

INDUSTRY

collaborator

Mclean Hospital

OTHER

collaborator

National Center for Research Resources (NCRR)

NIH

lead

Brigham and Women's Hospital

OTHER

NCT00555750 - Sleep Loss and Mechanisms of Impaired Glucose Metabolism | Biotech Hunter | Biotech Hunter